Your browser doesn't support javascript.
loading
Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.
Kawai, Akira; Goto, Toshio; Shibata, Tatsuhiro; Tani, Kenzaburo; Mizutani, Shuki; Nishikawa, Akiyoshi; Shibata, Taro; Matsumoto, Seiichi; Nagata, Kyosuke; Narukawa, Mamoru; Matsui, Shigeyuki; Ando, Masashi; Toguchida, Junya; Monden, Morito; Heike, Toshio; Kimura, Shinya; Ueda, Ryuzo.
Afiliação
  • Kawai A; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Goto T; Department of Musculoskeletal Oncology and Rehabilitation, Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.
  • Shibata T; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Tani K; Program for Drug Discovery and Medical Technology Platforms, RIKEN, Tsukuba, Japan.
  • Mizutani S; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Nishikawa A; Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Shibata T; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Matsumoto S; Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nagata K; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Narukawa M; Tokyo Medical and Dental University, Tokyo, Japan.
  • Matsui S; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Ando M; Biological Safety Research Center, National Institute of Health Sciences, Tokyo, Japan.
  • Toguchida J; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Monden M; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
  • Heike T; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Kimura S; Sarcoma Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Ueda R; Subcommittee on Rare Cancers, The Science Board to the Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Cancer Sci ; 109(5): 1731-1737, 2018 May.
Article em En | MEDLINE | ID: mdl-29878624
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Raras / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Raras / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão